TR202110941A2 - A TEST METHOD FOR DIAGNOSING COVID-19 DISEASE - Google Patents

A TEST METHOD FOR DIAGNOSING COVID-19 DISEASE

Info

Publication number
TR202110941A2
TR202110941A2 TR2021/010941A TR202110941A TR202110941A2 TR 202110941 A2 TR202110941 A2 TR 202110941A2 TR 2021/010941 A TR2021/010941 A TR 2021/010941A TR 202110941 A TR202110941 A TR 202110941A TR 202110941 A2 TR202110941 A2 TR 202110941A2
Authority
TR
Turkey
Prior art keywords
disease
test method
covid
cov
sars
Prior art date
Application number
TR2021/010941A
Other languages
Turkish (tr)
Inventor
Zengi̇n Mustafa
Köroğlu Mehmet
Karabay Oğuz
Original Assignee
Sakarya Ueniversitesi Rektoerluegue
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sakarya Ueniversitesi Rektoerluegue filed Critical Sakarya Ueniversitesi Rektoerluegue
Priority to TR2021/010941A priority Critical patent/TR202110941A2/en
Publication of TR202110941A2 publication Critical patent/TR202110941A2/en

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Buluş konusu, Covid-19 hastalığına neden olan SARS-CoV-2 virüslerinin varlığı ve aşı yapılan veya hasta olan kişilerde oluşan SARS-CoV-2 antikorların tespiti için kullanıma uygun, kısa sürelerde tayin edebilme, yüksek güvenilir ve düşük maliyetli özelliklerine sahip bir test düzeneği ve in-vitro kantitatif ve/veya kalitatif verilerin elde edilmesine yönelik test yöntemi ile ilgilidir.The subject of the invention is a test setup that is suitable for the detection of SARS-CoV-2 viruses that cause Covid-19 disease and the detection of SARS-CoV-2 antibodies in people who have been vaccinated or who are sick, with the features of being able to detect in a short time, high reliable and low cost. and the test method for obtaining in-vitro quantitative and/or qualitative data.

TR2021/010941A 2021-07-05 2021-07-05 A TEST METHOD FOR DIAGNOSING COVID-19 DISEASE TR202110941A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TR2021/010941A TR202110941A2 (en) 2021-07-05 2021-07-05 A TEST METHOD FOR DIAGNOSING COVID-19 DISEASE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2021/010941A TR202110941A2 (en) 2021-07-05 2021-07-05 A TEST METHOD FOR DIAGNOSING COVID-19 DISEASE

Publications (1)

Publication Number Publication Date
TR202110941A2 true TR202110941A2 (en) 2021-07-26

Family

ID=83394869

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2021/010941A TR202110941A2 (en) 2021-07-05 2021-07-05 A TEST METHOD FOR DIAGNOSING COVID-19 DISEASE

Country Status (1)

Country Link
TR (1) TR202110941A2 (en)

Similar Documents

Publication Publication Date Title
Moderbacher et al. NVX-CoV2373 vaccination induces functional SARS-CoV-2–specific CD4+ and CD8+ T cell responses
Truelove et al. A comparison of hemagglutination inhibition and neutralization assays for characterizing immunity to seasonal influenza A
Hamlin et al. Longitudinal monitoring of the development of antifilarial antibodies and acquisition of Wuchereria bancrofti in a highly endemic area of Haiti
McDougal et al. Comparison of HIV type 1 incidence observed during longitudinal follow-up with incidence estimated by cross-sectional analysis using the BED capture enzyme immunoassay
de Armas et al. Reevaluation of immune activation in the era of cART and an aging HIV-infected population
Muturi-Kioi et al. Neutropenia as an adverse event following vaccination: results from randomized clinical trials in healthy adults and systematic review
AR103935A1 (en) METHODS OF DETECTION AND QUANTIFICATION OF IL-13 AND ITS USES IN THE DIAGNOSIS AND TREATMENT OF DISEASES ASSOCIATED WITH TH-2
Fitzgerald et al. Diagnosing acute HIV infection at point of care: a retrospective analysis of the sensitivity and specificity of a fourth-generation point-of-care test for detection of HIV core protein p24
Luo et al. Kinetics of SARS-CoV-2 antibody avidity maturation and association with disease severity
Padoan et al. SARS-CoV-2 neutralizing antibodies after one or two doses of Comirnaty (BNT162b2, BioNTech/Pfizer): Kinetics and comparison with chemiluminescent assays
Sylvester et al. Conflict of evidence: resolving discrepancies when findings from randomized controlled trials and meta-analyses disagree
Dung et al. Seroprevalence survey of avian influenza A (H5N1) among live poultry market workers in northern Viet Nam, 2011
Agyemang et al. Performance of a novel rapid test for recent HIV infection among newly-diagnosed pregnant adolescent girls and young women in four high-HIV-prevalence districts—Malawi, 2017–2018
Stephan et al. Healthcare costs of congenital cytomegalovirus (cCMV) disease in infants during the first two years of life: a retrospective German claims database analysis
Metzger et al. Contribution of a IFN-y assay in contact tracing for tuberculosis in a low-incidence, high immigration area
TR202110941A2 (en) A TEST METHOD FOR DIAGNOSING COVID-19 DISEASE
Scicluna et al. Validation of an indirect ELISA employing a chimeric recombinant gag and env peptide for the serological diagnosis of equine infectious anemia
Shiroma et al. Visual inspection for determining days when accelerometer is worn: is this valid?
Santacruz-Sanmartín et al. Seroprevalence of mumps in an epidemic period in Medellín, Colombia
Liu et al. Evaluation of a domestic interferon-gamma release assay for detecting Mycobacterium tuberculosis infection in China
Srinivas et al. Utility of testing patients, on presentation, for serologic features of celiac disease
Uwamino et al. The utility of smartphone-based quantitative analysis of SARS-CoV-2-specific antibody lateral flow assays
Conrad et al. Conceptualizing and measuring financial exploitation and psychological abuse of elderly individuals
Liang et al. Reduction of anti-HIV antibody responses in subjects receiving antiretroviral therapy during chronic HIV-1 infection
CY1113013T1 (en) IMPROVED IMMUNE TEST METHODS